Pharmaceuticals - Bridgewater, New Jersey, United States
RVL Pharmaceuticals, Inc. is a new operating subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT), and was created for the purpose of bringing Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% to market. RVL Pharmaceuticals, Inc. is dedicated to developing unique partnerships with customers, as well as making Upneeq® available exclusively through our fully-owned and integrated pharmacy.Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.
Outlook
Apache
Google AdSense
Mailchimp Mandrill
Microsoft Office 365
Adobe Marketing Cloud